Zhong-Ming Qian, Yun-Jin Chen, Yu-Xin Bao: Pharmacological mechanisms of norcantharidin against hepatocellular carcinoma. Am J Cancer Res 2023;13(11):5024-5038. (Full text, PDF)
Toshiyuki Murai, Satoru Matsuda: Targeting the PI3K-Akt-mTOR signaling pathway involved in vasculogenic mimicry promoted by cancer stem cells. Am J Cancer Res 2023;13(11):5039-5046. (Full text, PDF)
You Wu, Ziqiao Liu, Panling Xu, Xin Sun, Ting Wang, Ping Li: Brucea Javanica Oil Emulsion Injection inhibits proliferation of pancreatic cancer via regulating apoptosis-related genes. Am J Cancer Res 2023;13(11):5047-5064. (Full text, PDF)
Huan Wang, Guang-Fa Xia, Zi-Ran Zhang, Xi Luo, Juan-Ying Zhu, Hui-Ke Wang: Development and validation of a prognostic nomogram for breast cancer patients who underwent chemoradiotherapy and surgery: a retrospective cohort study based on the SEER database and two Chinese cohorts. Am J Cancer Res 2023;13(11):5065-5081. (Full text, PDF)
Maobing Wang, Zhaowei Sun, Qinlei Wang, Jingyun Guo, Xueliang Li, Jie Chen, Bingyuan Zhang, Dongdong Dai, Yujie Feng: Establishment and validation of a nomogram model for preoperative prediction of the risk of cholangiocarcinoma with perineural invasion. Am J Cancer Res 2023;13(11):5082-5093. (Full text, PDF)
Wenchao Zhang, Rong He, Wenbing Cao, Dapeng Li, Qiping Zheng, Yiming Zhang: Oncogenic and immunological values of RBM34 in osteosarcoma and its pan-cancer analysis. Am J Cancer Res 2023;13(11):5094-5121. (Full text, PDF, Supplementary Table 3)
Ping Chen, Jiwen Liu, Kening Sun, Liru Wang, Xia Li, Xiang Li, Wei Jia, Xiaoyan Yuan: Methylation of TTC4 interaction with HSP70 inhibits pyroptosis in macrophages of sepsis-induced lung injury by NLRP3 inflammation. Am J Cancer Res 2023;13(11):5122-5137. (Full text, PDF)
Guangchao Lv, Shiyun Feng, Yan Zhang, Yang Li, Youbin Cui: Clinical therapeutic effects and prognosis of video-assisted thoracoscopic surgery-guided pulmonary lobectomy combined with mediastinal lymph node dissection in lung carcinoma. Am J Cancer Res 2023;13(11):5138-5150. (Full text, PDF)
Doan Huu Nhat Binh, Tzu-Chun Cheng, Shih-Hsin Tu, You-Cheng Liao, Yi-Yuan Yang, Li-Ching Chen, Yuan-Soon Ho: StAR-related lipid transfer domain protein 3 (STARD3) regulates HER2 and promotes HER2-positive breast cancer progression through interaction with HSP90 and SRC signaling. Am J Cancer Res 2023;13(11):5151-5173. (Full text, PDF)
Xin-Yue Zhang, Hao Zhang, Si-Jing Hu, Shun-Yao Liao, Da-Chang Tao, Xiao-Lan Tan, Ming Yi, Xiang-You Leng, Zhao-Kun Wang, Jia-Ying Shi, Sheng-Yu Xie, Yuan Yang, Yun-Qiang Liu: NR0B1 suppresses ferroptosis through upregulation of NRF2/c-JUN-CBS signaling pathway in lung cancer cells. Am J Cancer Res 2023;13(11):5174-5196. (Full text, PDF)
Zhichen Jiang, Shaobo Zhang, Huiju Wang, Chunfang Hu, Li Li, Xiaohao Zheng, Yongrun Mu, Fangxia Wang, Yiping Mou, Mingyang Liu, Weiwei Jin: Protocadherin-1 serves as a prognostic biomarker and promotes pancreatic cancer progression by suppressing CD8+ T cell infiltration through CCL5-CCR5 axis. Am J Cancer Res 2023;13(11):5197-5217. (Full text, PDF)
Wenmin Ji, Wenyan Wang, Yanfang Wei: TP53TG1/STAT axis is involved in the development of colon cancer through affecting PD-L1 expression and immune escape mechanism of tumor cells. Am J Cancer Res 2023;13(11):5218-5235. (Full text, PDF)
Xueying Wang, Yuzhang Gao, Rui Miao, Lisha Li, Abiyasi Nanding, Yong Liu, Xin Zhang: Risk model-guided identification of MTDH expression as a marker for ferroptosis induction therapy in head and neck squamous cell carcinoma. Am J Cancer Res 2023;13(11):5236-5253. (Full text, PDF)
Chen Sun, Wenwen Xu, Yunhong Xia, Shuomin Wang: PRDM16 from hepatic stellate cells-derived extracellular vesicles promotes hepatocellular carcinoma progression. Am J Cancer Res 2023;13(11):5254-5270. (Full text, PDF)
Je-Ming Hu, Pei-Yao Liu, Ying-Chuan Chen, Wei-Zhi Lin, Yu-Ching Chou, Wen-Chiuan Tsai, Chi-Ming Chu, Chia-Chao Wu, Yu-Tien Chang: A co-regulatory network of SPIB, AQP8, and GUCA2B related to immune infiltration for early-stage colorectal cancer in silico and in vitro. Am J Cancer Res 2023;13(11):5271-5288. (Full text, PDF)
Tiantian Zhou, Ziyi Xiao, Jin Lu, Lihua Zhang, Le Bo, Jinhua Wang: IGF2BP3-mediated regulation of GLS and GLUD1 gene expression promotes treg-induced immune escape in human cervical cancer. Am J Cancer Res 2023;13(11):5289-5305. (Full text, PDF)
Xiaoying Xu, Xinzhi Feng, Pengju Zhang, Xiaoyan Lin: A risk model based on ferroptosis- and cuproptosis-related lncRNAs predicts prognosis and immune microenvironment in lung adenocarcinoma by bioinformatics analysis and experimental verification. Am J Cancer Res 2023;13(11):5306-5319. (Full text, PDF, Supplementary Table 5)
Yuanzhou Wu, Hui Li, Yang Huang, Qunqing Chen: Silencing of m6A methyltransferase KIAA1429 suppresses the progression of non-small cell lung cancer by promoting the p53 signaling pathway and ferroptosis. Am J Cancer Res 2023;13(11):5320-5333. (Full text, PDF)
Abrar I Aljohani, Sami A Alsaeed, Michael S Toss, Sara A Raafat, Andrew R Green, Emad A Rakha: The expression of high mobility group protein 3 (HMGB3) in breast cancer with emphasis on its role in lymphovascular invasion. Am J Cancer Res 2023;13(11):5334-5351. (Full text, PDF)
Jeng-Yuan Tsai, Chia-Wei Weng, Yi-Hua Lai, Meng-Fang Tsai, Hsuan-Yu Chen, Jeremy JW Chen: Proscillaridin A inhibits lung cancer cell growth and motility through downregulation of the EGFR-Src-associated pathway. Am J Cancer Res 2023;13(11):5352-5367. (Full text, PDF)
Shenan Huang, Ming Xiong, Jie Liu, Jian Wang, Xianyang Han, Zhimeng Chen, Peiyi Xie, Zhipeng Zhou, Cong Liu, Hui Li, Zhili Wen, Xiaomei Huang, Binghai Zhou: Exosomes with IR780 and Lenvatinib loaded on GPC3 single-chain scFv antibodies for targeted hyperthermia and chemotherapy in hepatocellular carcinoma therapy. Am J Cancer Res 2023;13(11):5368-5381. (Full text, PDF)
Xin Xu, Guanting Wu, Kunkun Han, Ximao Cui, Yuan Feng, Xiao Mei, Peng Yang, Wendao You, Yili Yang: Inhibition of OTUB2 suppresses colorectal cancer cell growth by regulating β-Catenin signaling. Am J Cancer Res 2023;13(11):5382-5393. (Full text, PDF)
Wei Fu, Min Zhang, Yuxin Zhou, Shujun Zhang, Lei Dong, Liying Wang: Clinical study of classification and regression tree assisted endometrial biopsy in the diagnosis of endometrial carcinoma. Am J Cancer Res 2023;13(11):5394-5404. (Full text, PDF)
Xiaoqing Xu, Hualiang Ji, Zongfeng Guo, Xiaomin Lu: Elevated serum MMP-1 associated with advanced disease stage and lymph node metastasis in patients with pancreatic carcinoma. Am J Cancer Res 2023;13(11):5405-5417. (Full text, PDF)
Mengqian Mao, Qiuyun Yuan, Xiaoqiang Xia, Yiyuan Cui, Mina Chen, Wanchun Yang: Integrative analysis defines DDIT3 amplification as a correlative and essential factor for glioma malignancy. Am J Cancer Res 2023;13(11):5418-5430. (Full text, PDF)
Mei-Chun Zeng, Qing-Jun Jia, Jue Xu, Jing-Jing Chen, Kang Qin, Li-Ming Xu: The whole-blood Epstein-Barr virus DNA can serve as a valuable molecular marker for diagnosis and prognosis prediction of nasopharyngeal carcinoma. Am J Cancer Res 2023;13(11):5431-5442. (Full text, PDF, Supplementary Table 1)
Seul-Ki Lee, Yoonjung Hwang, Jae-Ho Han, Seokjin Haam, Hyun Woo Lee, Young Wha Koh: Characteristics of the immune microenvironment associated with RRM2 expression and its application to PD-L1/PD-1 inhibitors in lung adenocarcinoma. Am J Cancer Res 2023;13(11):5443-5454. (Full text, PDF)
Zhipeng Lin, Du Chen, Xiaolong Hu, Dabei Huang, Yuan Chen, Jian Zhang, Xiaoqun Li, Xugong Zou: Clinical efficacy of HAIC (FOLFOX) combined with lenvatinib plus PD-1 inhibitors vs. TACE combined with lenvatinib plus PD-1 inhibitors in the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombus and arterioportal fistulas. Am J Cancer Res 2023;13(11):5455-5465. (Full text, PDF)
Jenilson M Silva, Amanda J Deus, André A M Vale, Ana Paula S Azevedo-Santos, Leudivan Nogueira, Ana C Laus, Luciane Sussuchi, Rui M Reis, Alexander Birbrair, André S Khayat, Silma Regina Pereira: MIR-376A-2-5P as a potential prognostic marker for advanced penile squamous cell carcinomas trough HPV-dependent pathways. Am J Cancer Res 2023;13(11):5466-5481. (Full text, PDF, Supplementary Tables 1, 2, 3A, 3B, 3C, 4)
Chung-Wei Su, Wei Teng, Po-Ting Lin, Tsung-Han Wu, Yu-Chun Hsu, Yi-Chung Hsieh, Chien-Hao Huang, Wei-Ting Chen, Chen-Chun Lin, Chun-Yen Lin, Shi-Ming Lin: A combination of locoregional treatment with systemic therapy after atezolizumab plus bevacizumab failure for unresectable hepatocellular carcinoma provides survival benefit. Am J Cancer Res 2023;13(11):5482-5492. (Full text, PDF)
Taehee Kim, Hyun Chang, Binna Kim, Jaeho Yang, Dongjun Koo, Jeongwon Lee, Ji Wouk Chang, Gisu Hwang, Gyungyub Gong, Nam Hoon Cho, Chong Woo Yoo, Ju-Yeon Pyo, Yosep Chong: Deep learning-based diagnosis of lung cancer using a nationwide respiratory cytology image set: improving accuracy and inter-observer variability. Am J Cancer Res 2023;13(11):5493-5503. (Full text, PDF)
Ching-Feng Lien, Tzer-Zen Hwang, Tsun-Mei Lin, Kai-Wen Liu, Bor-Shyh Lin, Chih-Chun Wang, Chuan-Chien Yang, Shyh-An Yeh, Meng-Che Hsieh: Prognostic impact of cortactin in patients with hypopharyngeal cancer and its role for tegafur-uracil maintenance after adjuvant chemoradiotherapy. Am J Cancer Res 2023;13(11):5504-5512. (Full text, PDF)
Wenjie Yu, Xiaoling He, Chunming Zhang, Hui Huangfu: Transcriptomics data mining to uncover signature genes in head and neck squamous cell carcinoma: a bioinformatics analysis and RNA-sequencing based validation. Am J Cancer Res 2023;13(11):5513-5530. (Full text, PDF)
Wei Huang, Yanyan Hu, Xiaotao Zhang, Yan Xu, Zhiling Sun, Pingan Ding, Xiaoping Qian, Akbar Ali, Zilu Chen: Integrated multiplex network based approach reveled CC and CXC chemokines associated key biomarkers in colon adenocarcinoma patients. Am J Cancer Res 2023;13(11):5531-5548. (Full text, PDF)
Kaibin Huang, Shunkai Ding, Kai Chen, Chunhua Guo, Mingyi Wu, Rui Zhang, Luolin Wang, Yuxiang Fu, Jinfeng Xiao, Xianming Liu: RNF43 mutation as a predictor of immunotherapeutic efficacy in colorectal cancer. Am J Cancer Res 2023;13(11):5549-5558. (Full text, PDF)
Leisheng Zhang, Yuan Meng, Hao Yao, Rucai Zhan, Shuang Chen, Wenjing Miao, Shixun Ma, Xianghong Xu, Yonghong Li, Miao Yu, Yan Han, Wei Su, Zhihai Han, Tao Wang, Baoquan Song, Ping Wang, Hui Cai, Jianhui Yan: CAR-NK cells for acute myeloid leukemia immunotherapy: past, present and future. Am J Cancer Res 2023;13(11):5559-5576. (Full text, PDF)
Zhongmin Jiang, Xiaozhi Liu, Yongqing Deng, Duojierenqing, Renqingcuo, Wenhan Wu, Wei Meng, Zhijiang Shao: Detection of CSTF2 by nano fluorescent probe and its correlation with malignant biological characteristics in liver cancer. Am J Cancer Res 2023;13(11):5577-5589. (Full text, PDF)
Bing Quan, Wenfeng Liu, Fan Yao, Miao Li, Bei Tang, Jinghuan Li, Zhenggang Ren, Xin Yin: LINC02362/hsa-miR-18a-5p/FDX1 axis suppresses proliferation and drives cuproptosis and oxaliplatin sensitivity of hepatocellular carcinoma. Am J Cancer Res 2023;13(11):5590-5609. (Full text, PDF)
Xiongzhi Wangpu, Jingkun Zhao, Chaoran Yu, Song Yu, Hongcheng Wang, Zhou Yuan, Xinyu Huang: CircATP13A1 (hsa_circ_0000919) promotes cell proliferation and metastasis and inhibits cell apoptosis in pancreatic ductal adenocarcinoma via the miR-186/miR-326/HMGA2 axis: implications for novel therapeutic targets. Am J Cancer Res 2023;13(11):5610-5625. (Full text, PDF)
Eun Ho Kim: Tumor treating fields induced senescence on glioblastoma. Am J Cancer Res 2023;13(11):5626-5640. (Full text, PDF)
Satoru Furuhashi, Yoshifumi Morita, Akio Matsumoto, Shinya Ida, Ryuta Muraki, Ryo Kitajima, Makoto Takeda, Hirotoshi Kikuchi, Yoshihiro Hiramatsu, Hiroya Takeuchi: Tenascin C in pancreatic cancer-associated fibroblasts enhances epithelial mesenchymal transition and is associated with resistance to immune checkpoint inhibitor. Am J Cancer Res 2023;13(11):5641-5655. (Full text, PDF)
Fan Jiang, Yihuang Lin, Jie Du, Shi Qiu, Gang Luo, Ziqiang Zhang: The transcription factor TBP promotes hepatocellular carcinoma progression by activating AKT3. Am J Cancer Res 2023;13(11):5656-5666. (Full text, PDF)
Tao Wang, Caixia Zhang, Yue Gao, Hanwei Yang, Kewei Li, Jian Wang, Yi Wu: Predictive value of CRP combined with peripheral blood cell ratio for the prognosis of advanced NSCLC. Am J Cancer Res 2023;13(11):5667-5683. (Full text, PDF)
Jie Zhang, Weiqing Qiu, Wei Zhang, Yuanwen Chen, Huojian Shen, Hongyi Zhu, Xiaofei Liang, Zhiyong Shen: Tracking of trastuzumab resistance in patients with HER2-positive metastatic gastric cancer by CTC liquid biopsy. Am J Cancer Res 2023;13(11):5684-5697. (Full text, PDF)
Yiming Zhong, Chaoqun Wang, Yanmei Wang, Yan Wu, Hanying Wang, Shuying Qiu, Minyan Hao, Zhuo Wang, Xian Wang, Hongchuan Jin, Jia Zhou: Suppression of alpha-tubulin acetylation potentiates therapeutic efficacy of Eribulin in liver cancer. Am J Cancer Res 2023;13(11):5698-5718. (Full text, PDF)
Yu-Tien Chang, Zhi-Jie Hong, Jyh-Cherng Yu, Wei-Zhi Lin, Tzu-Ya Huang, Hsueh-Han Tsai, An-Chieh Feng, Kuo-Feng Hsu, Chi-Cheng Huang, Chi-Ming Chu, Chia-Ming Liang, Guo-Shiou Liao: Advancing breast cancer subtyping: optimizing immunohistochemical staining classification with insights from real-world Taiwanese data. Am J Cancer Res 2023;13(11):5719-5732. (Full text, PDF)
Chia-Lun Chang, Kuan-Chou Lin, Wan-Ming Chen, Ben-Chang Shia, Szu-Yuan Wu: Antihistamines H1 use on survival outcomes in esophageal squamous cell carcinoma patients undergoing concurrent chemoradiotherapy. Am J Cancer Res 2023;13(11):5733-5745. (Full text, PDF)
Xiwei Ding, Yiyang Zhang, Tianlu Huang, Guifang Xu, Chunyan Peng, Gang Chen, Bo Kong, Helmut Friess, Shanshan Shen, Ying Lv, Lewis R Roberts, Lei Wang, Xiaoping Zou: Targeting sphingosine kinase 2 suppresses cell growth and synergizes with BCL2/BCL-XL inhibitors through NOXA-mediated MCL1 degradation in cholangiocarcinoma: Am J Cancer Res. 2019; 9(3): 546-561. Am J Cancer Res 2023;13(11):5746-5747. (Full text, PDF)
Xiaofeng Jin, Jian Wang, Qian Li, Hui Zhuang, Jianye Yang, Zihan Lin, Ting Lin, Zeheng Lv, Liliang Shen, Chunhong Yan, Jingfei Zheng, Jie Zhu, Zhaohui Gong, Chenji Wang, Kun Gao: SPOP targets oncogenic protein ZBTB3 for destruction to suppress endometrial cancer: Am J Cancer Res. 2019; 9(12): 2797-2812. Am J Cancer Res 2023;13(11):5748-5749. (Full text, PDF)
Fanying Meng, Wan-Fen Li, Donald Jung, Chun-Chung Wang, Tianyang Qi, Chi-Sheng Shia, Ren-Yu Hsu, Yin-Cheng Hsieh, Jianxin Duan: A novel selective AKR1C3-activated prodrug AST-3424/OBI-3424 exhibits broad anti-tumor activity: Am J Cancer Res. 2021; 11(7): 3645-3659. Am J Cancer Res 2023;13(11):5750. (Full text, PDF)
